ENTITY

Solvonis Therapeutics (SVNS LN)

7
Analysis
Industrials • United Kingdom
Solvonis Therapeutics is a clinical-stage biopharmaceutical company developing novel medicines for high-burden central nervous system (CNS) disorders, with an initial focus on addiction and mental health. The company is advancing a pipeline of repurposed and novel compounds, including lead programs addressing Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD). Headquartered in London, United Kingdom, the company was founded in 2017.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x